Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated May 14, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2021. Go to the latest filing (Q3 2026)

12.5B USDQ1 2021
Total value of stock positions
12.5B USD
Positions
58
Share of the ten largest
65.0%

The ten largest positions Q1 2021

  1. Intel 11.9%▲ +28.2%
  2. Liberty Global PLC 11.1%unchanged
  3. eBay Inc. 9.0%▼ −41.1%
  4. Qorvo Inc 7.6%▲ +17.7%
  5. Viasat Inc 6.3%unchanged
  6. Alphabet Inc. (Class C) 4.8%▲ +265.6%
  7. Willis Towers Watson 4.6%new
  8. Micron Technology 3.8%▲ +3.9%
  9. Meta Platforms 3.0%▲ +41.0%
  10. PG&E Corporation 2.9%unchanged
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q1 2021

Positions Q1 2021 per 13F filing, 13 of 13
Symbol Weight in previous quarter Shares in previous quarter Value in previous quarter Change
MPC Marathon Petroleum 2.9% 7,690,721 318.1M USD sold out
Viacomcbs Inc 1.6% 4,700,000 175.1M USD sold out
Ajax I 0.6% 5,000,000 62.1M USD sold out
Redball Acquisition Corp 0.5% 4,950,000 53.9M USD sold out
Vesper Healthcare Acqstn Cor 0.4% 3,960,000 44.8M USD sold out
Avanti Acquisition Corp 0.4% 4,000,000 43.4M USD sold out
Reinvent Technology Partners 0.4% 3,500,000 42.9M USD sold out
Horizon Acquisition Corporat 0.3% 3,500,000 37.6M USD sold out
Broadstone Acquisition Corp 0.3% 2,970,000 31.2M USD sold out
Investindustrial Acquisition 0.2% 2,100,000 21.6M USD sold out
Radius Global Infrastrctre I 0.2% 1,501,342 19.3M USD sold out
Reinvent Technology Partners 0.1% 1,000,000 11.4M USD sold out
Vista Oil & Gas Sab De Cv < 0.1% 1,951,132 5.0M USD sold out
Plus 1 position in convertible bonds and bonds worth 30.6M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Biopharma Inc principal 30.0M USD 30.6M USD

Breakdown by sector

  • Technology 15.7%
  • Communication Services 11.6%
  • Consumer Discretionary 9.0%
  • Financials 4.6%
  • Utilities 2.9%
  • Materials 2.3%
  • Real Estate 1.3%
  • not in our coverage 52.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close